Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Breast Neoplasms and ERBB4[original query] |
|---|
| A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Dec 13 (24): 7506-14. Rokavec Matjaz, Justenhoven Christina, Schroth Werner, Istrate Monica Adina, Haas Susanne, Fischer Hans-Peter, Vollmert Caren, Illig Thomas, Hamann Ute, Ko Yon-Dschun, Glavac Damjan, Brauch Hiltr |
A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.
BMC medical genetics 2007 8 Suppl 1 S6. Murabito Joanne M, Rosenberg Carol L, Finger Daniel, Kreger Bernard E, Levy Daniel, Splansky Greta Lee, Antman Karen, Hwang Shih-J |
| A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.
Breast cancer research : BCR 2012 Mar 14 (2): 2. Kim HC, Lee JY, Sung H, Choi JY, Park SK, Lee KM, Kim YJ, Go MJ, Li L, Cho YS, Park M, Kim DJ, Oh JH, Kim JW, Jeon JP, Jeon SY, Min H, Kim HM, Park J, Yoo KY, Noh DY, Ahn SH, Lee MH, Kim SW, Lee JW, Park BW, Park WY, Kim EH, Kim MK, Han W, Lee SA, Matsuo K, Shen CY, Wu PE, Hsiung CN, Lee JY, Kim HL, Han BG, Kang D |
| ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer. PloS one 2014 9 (7): e102388. Kurppa Kari J, Rokavec Matjaz, Sundvall Maria, Kellokumpu-Lehtinen Pirkko-Liisa, Joensuu Heikki, Brauch Hiltrud, Elenius Kla |
| The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study. The Journal of pathology 2015 May . Guerini-Rocco Elena, Hodi Zsolt, Piscuoglio Salvatore, Ng Charlotte Ky, Rakha Emad A, Schultheis Anne M, Marchiò Caterina, da Cruz Paula Arnaud, De Filippo Maria R, Martelotto Luciano G, De Mattos-Arruda Leticia, Edelweiss Marcia, Jungbluth Achim A, Fusco Nicola, Norton Larry, Weigelt Britta, Ellis Ian O, Reis-Filho Jorge |
| Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proceedings of the National Academy of Sciences of the United States of America 2015 Jan 112 (4): 1107-12. Chen Kexin, Yang Da, Li Xiangchun, Sun Baocun, Song Fengju, Cao Wenfeng, Brat Daniel J, Gao Zhibo, Li Haixin, Liang Han, Zhao Yanrui, Zheng Hong, Li Miao, Buckner Jan, Patterson Scott D, Ye Xiang, Reinhard Christoph, Bhathena Anahita, Joshi Deepa, Mischel Paul S, Croce Carlo M, Wang Yi Michael, Raghavakaimal Sreekumar, Li Hui, Lu Xin, Pan Yang, Chang Han, Ba Sujuan, Luo Longhai, Cavenee Webster K, Zhang Wei, Hao Xish |
| Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution. Clinical breast cancer 2016 Jul . Edenfield Jessica, Schammel Christine, Collins Justin, Schammel David, Edenfield W Je |
| rs11895168 C allele and the increased risk of breast cancer in Isfahan population. Breast (Edinburgh, Scotland) 2016 Jun 28 89-94. Salimi Zohreh, Sadeghi Samira, Tabatabaeian Hossein, Ghaedi Kamran, Fazilati Mohamm |
| Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer. Molecular medicine reports 2016 Mar . Bagheri Fatemeh, Mesrian Tanha Hamzeh, Mojtabavi Naeini Marjan, Ghaedi Kamran, Azadeh Mansour |
| Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis. PLoS medicine 2016 Dec 13 (12): e1002201. Lefebvre Celine, Bachelot Thomas, Filleron Thomas, Pedrero Marion, Campone Mario, Soria Jean-Charles, Massard Christophe, Lévy Christelle, Arnedos Monica, Lacroix-Triki Magali, Garrabey Julie, Boursin Yannick, Deloger Marc, Fu Yu, Commo Frédéric, Scott Véronique, Lacroix Ludovic, Dieci Maria Vittoria, Kamal Maud, Diéras Véronique, Gonçalves Anthony, Ferrerro Jean-Marc, Romieu Gilles, Vanlemmens Laurence, Mouret Reynier Marie-Ange, Théry Jean-Christophe, Le Du Fanny, Guiu Séverine, Dalenc Florence, Clapisson Gilles, Bonnefoi Hervé, Jimenez Marta, Le Tourneau Christophe, André Fabri |
| Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Geyer Felipe C, Berman Samuel H, Marchiò Caterina, Burke Kathleen A, Guerini-Rocco Elena, Piscuoglio Salvatore, Ng Charlotte Ky, Pareja Fresia, Wen Hannah Y, Hodi Zoltan, Schnitt Stuart J, Rakha Emad A, Ellis Ian O, Norton Larry, Weigelt Britta, Reis-Filho Jorge |
| Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies. Breast cancer research : BCR 2017 7 19 (1): 87. Toomey Sinead, Eustace Alexander J, Fay Joanna, Sheehan Katherine M, Carr Aoife, Milewska Malgorzata, Madden Stephen F, Teiserskiene Ausra, Kay Elaine W, O'Donovan Norma, Gallagher William, Grogan Liam, Breathnach Oscar, Walshe Janice, Kelly Catherine, Moulton Brian, Kennedy M John, Gullo Guiseppe, Hill Arnold D, Power Colm, Duke Deirdre, Hambly Niamh, Crown John, Hennessy Bryan |
| The association between rs1972820 and the risk of breast cancer in Isfahan population. Journal of cancer research and therapeutics 0 13 (1): 26-32. Zabihi Narges, Sadeghi Samira, Tabatabaeian Hossein, Ghaedi Kamran, Azadeh Mansoureh, Fazilati Mohamm |
| Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer. Breast cancer research : BCR 2018 Aug 20 (1): 88. Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli |
| Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer. Therapeutic advances in medical oncology 2018 10 1758835918778297. Elster Naomi, Toomey Sinead, Fan Yue, Cremona Mattia, Morgan Clare, Weiner Gorzel Karolina, Bhreathnach Una, Milewska Malgorzata, Murphy Madeline, Madden Stephen, Naidoo Jarushka, Fay Joanna, Kay Elaine, Carr Aoife, Kennedy Sean, Furney Simon, Mezynski Janusz, Breathhnach Oscar, Morris Patrick, Grogan Liam, Hill Arnold, Kennedy Susan, Crown John, Gallagher William, Hennessy Bryan, Eustace Al |
| ErbB4 receptor polymorphism 2368A>C and risk of breast cancer. Breast (Edinburgh, Scotland) 2018 Dec 42 157-163. Mansouri Bidkani Masoumeh, Tabatabaeian Hossein, Parsafar Soha, Ghanei Nafezeh, Fazilati Mohammad, Ghaedi Kamr |
| ErbB4 3'-UTR Variant (c.*3622A>G) is Associated with ER/PR Negativity and Advanced Breast Cancer. Indian journal of clinical biochemistry : IJCB 2020 Jan 35 (1): 115-120. Tabatabian Maryam, Mesrian Tanha Hamzeh, Tabatabaeian Hossein, Sadeghi Samira, Ghaedi Kamran, Mohamadynejad Pari |
| Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer. Nature communications 2023 8 14 (1): 5112. Lei-Jie Dai, Ding Ma, Yu-Zheng Xu, Ming Li, Yu-Wei Li, Yi Xiao, Xi Jin, Song-Yang Wu, Ya-Xin Zhao, Han Wang, Wen-Tao Yang, Yi-Zhou Jiang, Zhi-Ming Sh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: